| L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH (NCT05315336) | Beijing Friendship Hospital | 2022-06-01 |
| Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis (NCT04551131) | St. Jude Children's Research Hospital | 2021-07-13 |
| Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH (NCT05137522) | Beijing Friendship Hospital | 2021-07-01 |
| DEP Combine With PD-1 Antibody as an Treatment for EBV-HLH (NCT05164978) | Beijing Friendship Hospital | 2021-05-01 |
| A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH） (NCT04326348) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-07-17 |
| Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. (NCT04077905) | Beijing Friendship Hospital | 2019-08-31 |
| Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis (NCT04120090) | Beijing Friendship Hospital | 2019-07-01 |
| Etoposide in the First-line Treatment of Adult EBV-HLH (NCT03742115) | Beijing Friendship Hospital | 2018-12-01 |
| Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU) (NCT03510650) | Charite University, Berlin, Germany | 2018-09-11 |
| DEP-Ru Regimen as a Salvage Therapy for HLH (NCT03533790) | Beijing Friendship Hospital | 2018-06-01 |
| Ruxolitinib Combined With Dexamethasone for HLH (NCT03795909) | Capital Research Institute of Pediatrics | 2017-03-01 |
| Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (NCT03259230) | Swedish Orphan Biovitrum | 2016-10-13 |
| L-DEP as an Initial Treatment for EBV-HLH (NCT02912702) | Beijing Friendship Hospital | 2016-09-01 |
| L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis (NCT02631109) | Beijing Friendship Hospital | 2015-12-01 |
| Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases (NCT02231710) | Bellicum Pharmaceuticals | 2015-02-01 |
| Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology (NCT02862054) | Beijing Friendship Hospital | 2015-01-01 |
| A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody (NCT02069899) | Swedish Orphan Biovitrum | 2014-08-04 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH) (NCT02007239) | Children's Hospital of Philadelphia | 2013-12-01 |
| Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) (NCT01998633) | Medical College of Wisconsin | 2013-12-01 |
| Immune Disorder HSCT Protocol (NCT01821781) | Washington University School of Medicine | 2013-04-29 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies (NCT01652092) | Masonic Cancer Center, University of Minnesota | 2012-09-04 |
| Administration of Donor T Cells With the Caspase-9 Suicide Gene (NCT01494103) | Baylor College of Medicine | 2011-11-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis (NCT01104025) | Children's Hospital Medical Center, Cincinnati | 2010-04-01 |
| Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 (NCT00426101) | Karolinska University Hospital | 2004-01-01 |
| Stem Cell Transplant for Immunologic or Histiocytic Disorders (NCT00176865) | Masonic Cancer Center, University of Minnesota | 2002-08-01 |
| T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders (NCT00176826) | Masonic Cancer Center, University of Minnesota | 2000-09-01 |
| Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies (NCT00006054) | Fairview University Medical Center | 2000-03-01 |
| Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders (NCT00006056) | Fairview University Medical Center | 2000-03-01 |